Risk of pneumonia with different inhaled corticosteroids in COPD patients: a meta-analysis
Q Zhang, S Li, W Zhou, X Yang, J Li… - COPD: Journal of …, 2020 - Taylor & Francis
ICS are anti-inflammatory agents which have been suggested to benefit people with
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …
Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
M Yang, Y Du, H Chen, D Jiang, Z Xu - International immunopharmacology, 2019 - Elsevier
Objective Inhaled corticosteroids (ICS) are generally used to treat patients with chronic
obstructive pulmonary disease (COPD) who suffer from repeated exacerbations. Recently, it …
obstructive pulmonary disease (COPD) who suffer from repeated exacerbations. Recently, it …
Inhaled corticosteroids and the pneumonia risk in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
H Chen, J Sun, Q Huang, Y Liu, M Yuan… - Frontiers in …, 2021 - frontiersin.org
Background: Whether all types of inhaled corticosteroids (ICSs) would increase the
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
C Janson, G Stratelis, A Miller-Larsson… - … journal of chronic …, 2017 - Taylor & Francis
Inhaled corticosteroids (ICSs) treatment combined with long-acting β2-adrenoceptor
agonists (LABAs) reduces the risk of exacerbations in COPD, but the use of ICSs is …
agonists (LABAs) reduces the risk of exacerbations in COPD, but the use of ICSs is …
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
C Crim, PMA Calverley, JA Anderson… - European …, 2009 - Eur Respiratory Soc
Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated
with chronic obstructive pulmonary disease (COPD). However, little is known about the risk …
with chronic obstructive pulmonary disease (COPD). However, little is known about the risk …
Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis
Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …
Risk of pneumonia associated with inhaled corticosteroid in patients with chronic obstructive pulmonary disease: a Korean population-based study
JH Lee, YH Park, DR Kang, SJ Lee… - … journal of chronic …, 2020 - Taylor & Francis
Introduction Inhaled corticosteroids (ICSs) are recommended for patients with frequent
exacerbation of chronic obstructive pulmonary disease (COPD). However, accumulating …
exacerbation of chronic obstructive pulmonary disease (COPD). However, accumulating …
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
DP Tashkin, M Miravitlles, BR Celli, N Metzdorf… - Respiratory …, 2018 - Springer
Background Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic
obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains …
obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains …
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study
CY Wang, CC Lai, WC Yang, CC Lin… - … Journal of Chronic …, 2016 - Taylor & Francis
To investigate the association between inhaled corticosteroid (ICS) exposure patterns and
the risk of pneumonia in chronic obstructive pulmonary disease (COPD) patients, we …
the risk of pneumonia in chronic obstructive pulmonary disease (COPD) patients, we …
相关搜索
- copd patients risk of pneumonia
- inhaled steroids risk of pneumonia
- copd patients life quality
- scientific rationale risk of pneumonia
- inhaled corticosteroid use in patients
- copd patients inhaled corticosteroid
- copd patients meta analysis
- corticosteroid use risk of pneumonia
- meta analysis risk of pneumonia
- pneumonia in patients inhaled corticosteroids
- serious pneumonia inhaled corticosteroids
- inhaled corticosteroid life quality
- pneumonia in patients meta analysis
- corticosteroid use pneumonia in copd
- scientific rationale pneumonia in copd
- risk of serious pneumonia